Hematopoiesis is a fundamental biological process that underlies the production of all blood and immune cells, and consequently drives immune function, oxygen transport, and tissue homeostasis. Alterations in hematopoiesis can lead to a wide spectrum of disorders—ranging from common conditions such as anemia and other cytopenias, to immunodeficiencies, inflammatory/rheumatologic disorders, and blood cancers (e.g., leukemias). Given the vital role of hematopoiesis in health and disease, this conference will explore the molecular and cellular mechanisms that govern blood cell development and maintenance, highlight the latest technological advances in the field, and underscore the broader public health relevance of this research.

Meeting Goals and Program Highlights

1. Advance Current Research: Attendees will discuss cutting-edge discoveries in hematopoietic stem cell biology, transcriptional regulation, and epigenetics. The program will showcase emerging tools such as single-cell multi-omics and CRISPR-based gene editing, which enable deeper insights into the origins of hematopoietic dysfunction and provide avenues for innovative therapies.

2. Facilitate Translation: By bridging basic, translational, and clinical research, the meeting will foster collaborations that can expedite the development of new diagnostic tools and treatments. Sessions will connect bench-side research findings to clinical applications, emphasizing how breakthroughs can be quickly translated to patient care.

3. Engage a Broad Community: The conference is designed for scientists, clinicians, trainees, industry representatives, and other stakeholders in immunology, regenerative medicine, molecular biology, and related fields. Inclusive poster sessions, panel discussions, and networking events will promote cross-disciplinary partnerships.

What Sets This Meeting Apart
Unlike other hematology or immunology meetings that may only focus on isolated aspects of blood biology or particular disease entities, this conference offers a comprehensive exploration of the entire continuum of hematopoiesis. From fundamental stem cell regulation to the application of novel therapeutics, this program uniquely integrates both basic science and clinical perspectives. This breadth ensures that participants gain a holistic understanding of blood cell development and the pathogenic mechanisms underlying various hematologic disorders, ultimately sparking new research directions and collaborations.

Joint Meeting with “Myeloid Cells”
A key feature of this year’s event is its joint format with the “Myeloid Cells” meeting. This partnership will provide valuable insights into the interconnected roles of hematopoietic stem cells and myeloid lineages—encompassing monocytes, macrophages, granulocytes, and dendritic cells—in both health and disease. Through shared sessions and networking opportunities, attendees will examine how dysregulation in myeloid cells contributes to pathologies such as chronic inflammation and malignancies, thereby gaining an integrated view of hematopoiesis that offers richer perspectives for future research and therapeutic strategies.

Anticipated Outcomes

1. Knowledge Exchange: Participants will leave with a deeper understanding of the mechanisms driving normal and abnormal hematopoiesis, which can immediately inform ongoing studies.

2. Collaboration & Innovation: The program emphasizes opportunities to form new partnerships, potentially accelerating discoveries that translate into improved interventions for hematopoietic disorders.

3. Public Health Impact: By linking basic science breakthroughs to clinical applications, the meeting underscores the urgency of advancing research on hematopoiesis to combat a wide array of blood-related illnesses and bolster overall public health.

Overall, this conference aims to serve as a premier forum for fostering scientific dialogue, generating innovative research ideas, and ultimately improving patient outcomes through transformative advances in hematopoiesis. Attendees will benefit from an unparalleled scope of topics, interactive sessions, and collaborations that distinguish this event from other meetings in the field.